- Home
- RFM vs NTRB Comparison
RFM vs NTRB Comparison
Compare RFM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFM
- NTRB
- Stock Information
- Founded
- RFM 2020
- NTRB 2016
- Country
- RFM United States
- NTRB United States
- Employees
- RFM N/A
- NTRB N/A
- Industry
- RFM Finance/Investors Services
- NTRB Industrial Specialties
- Sector
- RFM Finance
- NTRB Health Care
- Exchange
- RFM Nasdaq
- NTRB Nasdaq
- Market Cap
- RFM 92.3M
- NTRB 84.1M
- IPO Year
- RFM N/A
- NTRB N/A
- Fundamental
- Price
- RFM $15.71
- NTRB $7.46
- Analyst Decision
- RFM
- NTRB Buy
- Analyst Count
- RFM 0
- NTRB 1
- Target Price
- RFM N/A
- NTRB $13.00
- AVG Volume (30 Days)
- RFM 20.7K
- NTRB 216.4K
- Earning Date
- RFM 01-01-0001
- NTRB 12-04-2024
- Dividend Yield
- RFM 9.74%
- NTRB N/A
- EPS Growth
- RFM N/A
- NTRB N/A
- EPS
- RFM N/A
- NTRB N/A
- Revenue
- RFM N/A
- NTRB $2,021,771.00
- Revenue This Year
- RFM N/A
- NTRB $7.95
- Revenue Next Year
- RFM N/A
- NTRB $538.25
- P/E Ratio
- RFM N/A
- NTRB N/A
- Revenue Growth
- RFM N/A
- NTRB N/A
- 52 Week Low
- RFM $12.89
- NTRB $2.22
- 52 Week High
- RFM $16.41
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- RFM 62.46
- NTRB 55.21
- Support Level
- RFM $15.51
- NTRB $6.68
- Resistance Level
- RFM $15.76
- NTRB $8.24
- Average True Range (ATR)
- RFM 0.11
- NTRB 0.74
- MACD
- RFM 0.02
- NTRB -0.11
- Stochastic Oscillator
- RFM 79.22
- NTRB 43.32
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.